June 25, 2021 — Breast cancer recently surpassed lung cancer as the number 1 diagnosed cancer in the U.S., excluding nonmelanoma skin cancer. Additionally, the National Cancer Institute recently predicted an almost 10,000 excess deaths from breast and colorectal cancers over the next 10 years as a direct result of the pandemic, making it now more important than ever for women to take control over their breast health. Recently, Randy Hicks, M.D., MBA, Co-Owner and CEO of Regional Medical Imaging (RMI) in Michigan, participated in a nationwide satellite media tour to discuss how new technology is helping the fight against breast cancer.
The COVID-19 pandemic brought routine health screenings, such as mammograms, to a screeching halt, declining up to 92% in some areas last year, according to a study in the Journal of the American College of Radiology. Now, with Americans getting vaccinated and infection rates decreasing around the country, many women are playing catch-up on these vital health screenings, which leads to another issue — a drastic increase in workload for doctors, who must face a surge of patients who need to be screened.
Fortunately, an innovative new tool is available to help clinicians cope with this sudden demand, which at the same time provides them a higher degree of accuracy than ever before. ProFound AI uses the latest in deep-learning artificial intelligence (AI) and is clinically proven to help radiologists read mammograms more than 50% faster - and with more accuracy - while also reducing false positives and unnecessary callbacks, which can be stressful for women.
ProFound AI was the first 3D tomosynthesis software using AI to be cleared by the FDA. A video accompanying this announcement is available here: https://youtu.be/7nWf973J1ww.
For more information: icadmed.com
October 19, 2026 
